These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 17117054)
1. Dialyzer fiber bundle volume during hemodialysis using large-surface dialyzers. Leblanc M; Lafrance JP; Renald A ASAIO J; 2006; 52(6):646-51. PubMed ID: 17117054 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser. Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946 [TBL] [Abstract][Full Text] [Related]
3. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study. Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097 [TBL] [Abstract][Full Text] [Related]
4. [Clinical usefulness of Nephral ST dialyzers in hemodialyzed patients with increased risk of bleeding]. Kopeć J; Sułowicz W Przegl Lek; 2010; 67(2):91-4. PubMed ID: 20557006 [TBL] [Abstract][Full Text] [Related]
5. Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial. Islam MS; Hassan ZA; Chalmin F; Vido S; Berrada M; Verhelst D; Donnadieu P; Moranne O; Esnault VL Am J Kidney Dis; 2016 Nov; 68(5):752-762. PubMed ID: 27344212 [TBL] [Abstract][Full Text] [Related]
6. The influence of dialyzer geometry on blood coagulation and biocompatibility. Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717 [TBL] [Abstract][Full Text] [Related]
7. Measurement of fiber bundle volume in reprocessed dialyzers. Narsipur SS Clin Nephrol; 2004 Feb; 61(2):130-3. PubMed ID: 14989633 [TBL] [Abstract][Full Text] [Related]
8. Dialyzer fiber bundle volume and kinetics of solute removal in continuous venovenous hemodialysis. Liangos O; Sakiewicz PG; Kanagasundaram NS; Hammel J; Pajouh M; Seifert T; Paganini EP Am J Kidney Dis; 2002 May; 39(5):1047-53. PubMed ID: 11979349 [TBL] [Abstract][Full Text] [Related]
9. Does an alteration of dialyzer design and geometry affect biocompatibility parameters? Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675 [TBL] [Abstract][Full Text] [Related]
10. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding. Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846 [TBL] [Abstract][Full Text] [Related]
13. In vivo measurement of hemodialyzer fiber bundle volume: theory and validation. Krivitski NM; Kislukhin VV; Snyder JW; MacGibbon DR; Kuznetsova OA; Reasons AM; Depner TA Kidney Int; 1998 Nov; 54(5):1751-8. PubMed ID: 9844155 [TBL] [Abstract][Full Text] [Related]
14. Hemodialysis without heparin: a randomized, controlled, crossover study of two dialysis membranes (AN69ST and polysulfone F60). Brunet P; Frances J; Vacher-Coponat H; Jaubert D; Lebrun G; Gondouin B; Duval A; Berland Y Int J Artif Organs; 2011 Dec; 34(12):1165-71. PubMed ID: 22198602 [TBL] [Abstract][Full Text] [Related]
15. Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status. Morena M; Jaussent I; Chalabi L; Bargnoux AS; Dupuy AM; Badiou S; Rakic C; Thomas M; Canaud B; Cristol JP; Michel F Hemodial Int; 2010 Oct; 14(4):403-10. PubMed ID: 20955273 [TBL] [Abstract][Full Text] [Related]
16. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane. Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457 [TBL] [Abstract][Full Text] [Related]
17. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients. Low CL; Bailie G; Morgan S; Eisele G Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524 [TBL] [Abstract][Full Text] [Related]
18. Improved dialyzer reuse after use of a population pharmacodynamic model to determine heparin doses. Ouseph R; Brier ME; Ward RA Am J Kidney Dis; 2000 Jan; 35(1):89-94. PubMed ID: 10620549 [TBL] [Abstract][Full Text] [Related]
19. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal. Krieter DH; Lemke HD; Wanner C Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309 [TBL] [Abstract][Full Text] [Related]